|
HS Code |
880737 |
| Generic Name | Primidone |
| Brand Names | Mysoline |
| Drug Class | Barbiturate anticonvulsant |
| Mechanism Of Action | Metabolized to phenobarbital and phenylethylmalonamide, enhances GABA-mediated neuronal inhibition |
| Primary Use | Treatment of epilepsy and seizures |
| Route Of Administration | Oral |
| Half Life | 10-12 hours (primidone), 53-140 hours (phenobarbital metabolite) |
| Legal Status | Prescription only |
| Pregnancy Category | Category D (USA) |
| Side Effects | Drowsiness, ataxia, dizziness, nausea, depression, rash |
| Contraindications | Porphyria, hypersensitivity to primidone or barbiturates |
| Metabolism | Hepatic |
| Excretion | Renal |
As an accredited Primidone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Primidone is typically supplied in a white, opaque plastic bottle containing 100 tablets (250 mg each), labeled with drug information and warnings. |
| Shipping | Primidone should be shipped in tightly sealed, clearly labeled containers, protected from light, moisture, and physical damage. It must comply with regulatory guidelines, including those for hazardous materials if applicable. Ensure temperature control as specified by the manufacturer and provide appropriate documentation for safe handling and emergency response during transit. |
| Storage | Primidone should be stored in a tightly closed container at room temperature, preferably between 20°C and 25°C (68°F to 77°F), away from light, moisture, and heat. It should be kept in a dry area, separate from incompatible substances, and out of reach of children and unauthorized personnel. Ensure adequate ventilation in the storage area. |
|
Purity 99%: Primidone with purity 99% is used in pharmaceutical manufacturing, where it ensures consistent anticonvulsant efficacy in tablet formulations. Molecular weight 218.25 g/mol: Primidone with molecular weight 218.25 g/mol is used in antiepileptic drug development, where it provides accurate dosing for sustained seizure control. Stability temperature 25°C: Primidone with stability temperature of 25°C is used in long-term storage conditions, where it maintains chemical integrity and therapeutic effectiveness. Melting point 279°C: Primidone with melting point 279°C is used in solid oral dosage processing, where it enables reliable compaction and tablet formation. Particle size <50 micron: Primidone with particle size below 50 micron is used in suspension preparations, where it improves solubility and bioavailability. Assay ≥98%: Primidone with assay of at least 98% is used in quality-controlled pharmaceutical production, where it ensures batch-to-batch potency and safety. Solubility in water 0.1 g/100 ml: Primidone with solubility in water at 0.1 g/100 ml is used in solution formulation testing, where it provides controlled drug release profiles. Residual solvent <0.5%: Primidone with residual solvent content below 0.5% is used in compliant medicinal synthesis, where it minimizes toxicological risks. Specific optical rotation ±0.1°: Primidone with specific optical rotation of ±0.1° is used in enantiomeric purity assessments, where it ensures pharmacological consistency. Moisture content <1%: Primidone with moisture content less than 1% is used in dry powder tablet manufacturing, where it prevents degradation and caking. |
Competitive Primidone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Living with epilepsy means juggling a lot—uncertainty, stress, and the constant search for dependable support. The foundation for so many people comes down to quality seizure control, and that’s where Primidone steps in as a tried-and-true option. Doctors all over the world have leaned on Primidone for decades as a treatment tool for various types of epileptic seizures, including grand mal (tonic-clonic) and partial seizures. Its reputation isn’t just built on longevity—it comes from honest results observed both in clinic visits and daily experience.
Primidone delivers more than a single advantage. Its underlying value lies in its consistency. The product doesn’t jump in and out of popularity based on trends—it has stood the test of time. Take a look at its chemical backbone: Primidone belongs to the class of barbiturate anticonvulsants. It acts by lowering abnormal electrical activity in the brain, which really matters for people who rely on steady control. Always taken by mouth, the tablet or oral suspension format fits easily into daily routines. Standard tablets come in multiple strengths, usually 50 mg or 250 mg, lending flexibility. This isn’t just a technical detail—it allows doctors to fine-tune each patient’s dose, putting patients’ needs in the foreground.
So what sets Primidone apart from newer anti-seizure drugs? In a world obsessed with the latest and greatest, it’s easy to overlook the trustworthy medicine that’s never left the scene. Newer drugs claim fewer side effects, but Primidone’s record remains transparent. Its metabolism converts part of the dose into phenobarbital, which gives extra coverage for breakthrough seizures. While this dual-action sounds scientific, it really just means better backup during unpredictable situations.
From my own experience listening to patients—and spending years among caregivers and doctors—Primidone shows up as a solid anchor for many families. Parents caring for children with generalized tonic-clonic epilepsy often talk about nights where the calm after a seizure-free day feels like lifting a heavy weight. Teenagers dealing with partial seizures have described how finally sticking with Primidone gave them the confidence to join after-school activities without the constant fear of an episode. These stories don't make headlines, but they do shape lives. Primidone’s greatest selling point often becomes its role as an “old reliable.” The medicine may originate from another era, but its safety and effectiveness keep it relevant today.
Using Primidone means working with your doctor to chart a reasonable starting dose. Most people begin with a low amount, allowing their bodies a chance to adjust, and the dose gradually steps up. This minimizes side effects, which can include sleepiness or feeling lightheaded, especially during the first few days. Doctors check levels in the blood and tune the dose to match both seizure frequency and daytime alertness. Sometimes other medicines come into play, so your doctor may tweak dose amounts to help avoid problems like drug interactions or increased sleepiness.
Children can take Primidone too. Pediatric neurologists often choose it for kids who haven’t responded well to other medicines. In younger patients, the body processes the drug a bit differently, so medical teams watch closely. The key to safe use lies in partnership: regular check-ins, candid conversations about side effects or breakthrough seizures, and ongoing encouragement from family and clinicians. No fancy technology can replace that steady human support around medication adjustments.
One challenge seen with Primidone is the range of dosing schedules. Some folks need to take it two or three times a day. Skipping or missing a dose isn’t trivial—levels in the blood drop quickly, and that increases the risk for breakthrough seizures. Everyday routines like school, work, and family events sometimes pose obstacles. A pillbox or alarm helps ensure each dose lands on time. More than once, a caregiver has shared how a simple smartphone reminder prevented a missed midday dose—and a possible hospital visit.
Pharmacy shelves look crowded with choices for controlling epilepsy now. Doctors weigh options like lamotrigine, levetiracetam, valproate, and carbamazepine daily. Modern brands often promise fewer side effects and easier dosing. But Primidone still earns respect. In direct comparison, many new drugs cost much more—some come with complicated monitoring or insurance battles. Primidone sidesteps the red tape. Generic forms mean a smaller bill at the pharmacy, making it accessible for more families.
People talk a lot about side effect profiles. With Primidone, the main issues are drowsiness, trouble with coordination, and sometimes mild stomach upset or mood changes. Over time, many patients adjust as their bodies get used to the medication. Some folks notice less drowsiness than what they first expect. A healthy diet, staying hydrated, and keeping up with sleep help smooth the adjustment. By contrast, newer medications occasionally surprise patients with unusual rashes, ballpark mood swings, weight changes, or increased infection risk.
Primidone isn’t the right choice for everyone. Some people with liver problems or certain types of inherited metabolic conditions may steer clear. That’s why doctors dig into personal health history before recommending it. For those who make it work, though, the value comes back to peace of mind. The medicine’s long track record means that doctors know what to expect when monitoring patients. And, if something does feel off, there’s plenty of know-how in the neurology community to troubleshoot quickly.
Conversations about safety and long-term harm always surface with medications used daily over many years. Primidone stands on solid ground. Decades of use have mapped out most risks. In rare cases, people have noticed bone weakening—osteoporosis—after many years of continuous barbiturate-type seizure medicines. Doctors now often check vitamin D and bone health, especially in older adults and children growing quickly. Balance comes from weighing rare side effects against the dangers of uncontrolled seizures. Unplanned falls, injuries, and the psychological toll of living “on edge” can mount up fast if a medication loses its punch. Regular bloodwork catches any signs of liver or blood cell trouble well before serious problems arise.
Some folks worry about dependency, since Primidone has a chemical cousin in phenobarbital—a known sedative. At epilepsy doses, the risk of addiction or abuse stays low. Long-term patients focusing on seizure control almost never develop habits, since doses remain stable and the goal centers on safety, not sedation.
Women planning pregnancy have special questions about seizure medicines. Doctors and researchers pay close attention to women of childbearing age, since seizure control and fetal health both matter. Primidone carries some potential risk during pregnancy, as do many anti-epileptic medicines. Neurologists work closely with obstetricians to plan ahead, sometimes shifting treatment or adding supplements like folic acid to lower risks for the baby. Transparent conversation upfront paves the way for a smoother journey—families can rest a little easier knowing every option has been weighed.
Numbers and side effects only tell half the story. For most patients, medicines become part of the background of daily life. One college student I met, managing partial seizures, described how he tucked his pillbox in his backpack next to his notebooks. “It took the worry out of finals week,” he said. “I could focus on my work instead of constantly watching the clock for signs of trouble.” His experience mirrored dozens of others who got back to work, hobbies, and everyday activity thanks to steady seizure control.
Seniors dealing with new-onset seizures have shared similar experiences. For one retired teacher, switching to Primidone let her return to volunteer work at the library. Stigma fades when conversations open up. Quality of life improves not just with the absence of seizures, but with the relief that comes from sharing a meal with friends and leaving the fear of public episodes behind.
There’s comfort in knowing that something as dependable as Primidone remains an option, especially for those who haven’t found luck with flashier, newer drugs. Budget-conscious adults and families balancing multiple prescriptions often place affordable, well-understood options at the top of their list. The generic nature of Primidone translates to wider availability—important when insurance coverage runs thin or pharmacy supply chains hit a snag.
No medicine is perfect. Primidone sometimes causes drowsiness that cuts into alertness at school or work. Some patients experience fine hand tremors or trouble concentrating for a few weeks during dose adjustments. Doctors often offer strategies to manage these early hurdles, like scheduling doses to avoid heavy sleepiness during work hours or shifting homework to evenings. Dietary advice and encouragement from support groups also play a big role. As with all anti-epileptic medicines, regular communication helps ensure no one feels alone during the adjustment.
There’s also the issue of age. Young children and elderly patients process drugs differently compared to adults. Pediatric neurologists often start low and go slow, spacing out dose increases to minimize risk. Seniors might need dose checks after any new health scare, new prescription, or change in daily routine. The wisdom here comes not from a textbook, but from the stories of hundreds of families who share feedback and creative solutions in doctor’s offices and online communities.
Families facing tough choices in parts of the world where medical resources are stretched find comfort in medicines like Primidone. You don’t need a specialist hospital or high-tech lab to get started. Consistent results foster local trust. In the smallest towns, community clinics keep the medication in stock, making sure people facing epilepsy aren’t left behind when budgets tighten.
Affordable epilepsy care has ripple effects reaching far outside the neurologist’s office. In places where income runs thin, access to old, proven medicines can mean the difference between sending a child to school or keeping them home out of fear. Rural clinics often rely on medications like Primidone, which come with a wealth of published studies and practical tips passed down over the years. Generic status matters. While flashy advertising draws eyes to newer products, Primidone’s value comes through word of mouth and results.
Policy makers and nonprofit healthcare groups sometimes look past “older” medicines while hunting for cutting-edge solutions. Yet high costs can shut doors for families with limited means. The right answer may not always be the most high-tech one—it’s about fit and follow-through. Primidone fits the budget for many national health programs and social insurance schemes. In areas recovering from natural disasters or recent conflicts, stable supply chains mean refill access and fewer treatment gaps for epilepsy patients.
People facing epilepsy often live in silence due to stigma, especially in communities without open conversation about neurological conditions. A trusted medication, regularly stocked and well-supported by clinicians, builds a safety net for families balancing health with school and work. Outreach programs in different countries point to Primidone’s role in helping restart interrupted routines. From local pharmacists to rural health workers, the medicine arrives with clear instructions, peer networks for support, and detailed dosing guidelines developed through years of trial and improvement.
Despite advances in medicine, researchers continue to study barbiturate drugs like Primidone. Newer studies look at long-term brain health, best practices for switching medicines, and smarter ways to track medication side effects. Some research teams focus on tweaking dose schedules or combining Primidone with newer options for patients struggling with refractory epilepsy. Teamwork here strengthens outcomes. Doctors, caregivers, and patients bring their stories and struggles to the table, shaping research priorities and fueling the next wave of clinical trials.
Education matters just as much as any chemical breakthrough. Community workshops and epilepsy foundations run regular seminars for families, teachers, and employers. Primidone usually takes a central role in these talks—not just as a product, but as a bridge between generations. Grandparents mention their experience to parents navigating new diagnoses in children. Each shared story lowers barriers and gives newcomers a chance to learn the ropes without reinventing the wheel.
Transparency and trust must remain central. Pharmaceutical companies and medical journals regularly publish data on side effects, rare complications, and comparative studies. Honest reporting empowers patients and doctors to discuss risks, swap ideas, and search for alternatives if struggles surface. The role of Primidone in the marketplace isn’t about marketing spin—it’s about open conversation and real-world impact.
The path to better epilepsy care runs on a few key ideas: reliable supply, patient education, regular follow-up, and creative teamwork among care teams. Medical staff often recommend keeping a written medication log, including dose times, seizure frequency, and any side effects. This habit removes the guesswork during appointments and makes dose adjustments faster and safer. Families setting up check-ins at regular intervals spot problems early and avoid repeat hospital trips.
Support groups also play a game-changing role. Peer-to-peer networks share ideas on handling drowsiness, staying on schedule, navigating side effects, and advocating for better access. Community pharmacists step in to explain the ins and outs of Primidone to new patients, demystifying both the product and the disease. They also help track refills and flag possible drug interactions, serving as another set of eyes and ears on the front lines.
Doctors deserve better training on the realities of living with seizure risk. Medical schools and continuing education programs now place greater focus on up-to-date epilepsy care. Specialists draw on detailed patient histories and collaborate with primary care teams to ensure patients don’t slip through the cracks during life transitions – like going away to college, changing jobs, or planning a pregnancy. The goal isn’t just reducing seizure frequency, but creating a network where each piece—counseling, nutrition, social support, and medical care—fits together.
In the gallery of seizure medicines, Primidone might not draw the brightest spotlight, but its honest track record gives it staying power. Generations have trusted its steady, straightforward approach to epilepsy care. Its combination of affordability, clinical know-how, and access across regions keeps it near the top of the list for many families and health teams. Listening to those who use Primidone daily sharpens that verdict even further. Safe use, reliable support from doctors and pharmacists, and a willingness to adapt—these are the real ingredients that make a difference.
In busy clinics and quiet homes alike, Primidone continues to prove that sometimes, the clearest answer to a modern problem lives in a solution that’s been close by all along. Every patient’s story adds another page to its history—a testament to the strength found in persistence, honesty, and practical wisdom.